Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |